NDC product
Hemorrhoidal
NDC 11822-2944 · Rite Aid Corporation
Key facts
| Product NDC | 11822-2944 |
|---|---|
| Proprietary name | Hemorrhoidal |
| Nonproprietary name | glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum |
| Substances | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, PETROLATUM |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | Rite Aid Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M015 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE] and 2 more |
| Marketing start | Feb 27, 2020 |
| Marketing end | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory